Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Material AgreementItem 1.01 · 8-KMEDIUM RiskNeutral

CEL-SCI CORPORATION

cel-sci.com
Filed: Jun 14, 2026CIK: 0000725363Healthcare
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

CEL-SCI Corporation raised $2.5 million through a stock offering of 2.5 million shares at $1.00 per share, closing on June 16, 2026. The proceeds will fund development of Multikine and general corporate operations, providing near-term capital for the company's clinical and operational initiatives.

Key Takeaways

CEL-SCI completed a $2.5 million equity offering at $1.00 per share, generating gross proceeds before fees and expenses

ThinkEquity LLC served as the placement agent for the transaction, which closed on June 16, 2026

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJun 14, 2026
Item1.01
CategoryMaterial Agreement
CIK0000725363
Accession #0000725363
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
stock offeringmaterial agreement

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings